The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.
Open accessAbstract
The relation between high density lipoprotein cholesterol (HDL-C) and the development of myocardial infarction was examined in 2425 subjects, aged 50 to 79 years, who were enrolled in the Framingham Study from 1969 to 1971. After 12 years of follow-up, men in the bottom three quartiles of HDL-C (less than or equal to 52 mg/dl) experienced a 60% to 70% excess of myocardial infarction as compared to men whose HDL-C levels were higher (p less than 0.05). The effect of HDL-C was especially strong in women. In separate comparisons to the 4th quartile of HDL-C (greater than or equal to 67 mg/dl), the risk of myocardial infarction increased from a fourfold excess in the adjacent 3rd quartile (56 to 66 mg/dl, p less than 0.01) to a nearly sixfold excess in the 1st quartile (less than or equal to 46 mg/dl, p less than 0.001). These results persisted after adjusting for age and other risk factors. In addition, a significant effect of HDL-C remained in subjects who had the lowest concentrations of total cholesterol (less than or equal to 192 mg/dl in men and 211 mg/dl in women) in which 29% had levels of HDL-C (less than or equal to 36 mg/dl in men and 46 mg/dl in women) that were associated with a marked elevation in the incidence of myocardial infarction. We conclude that screening for total cholesterol alone in men and women aged 50 and older may not adequately identify the coronary candidate.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lerner, D. J., & Kannel, W. B. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90155-9 · Cited by 1,725
Self-citationIncidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
Self-citationAN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY
Dawber, T. R., Kannel, W. B., & Lyell, L. P. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13299.x · Cited by 560
Self-citationAnalysis of Covariance and Standardization as Instances of Prediction
Lane, P. W., & Nelder, J. A. (1982) · Biometrics · doi:10.2307/2530043 · Cited by 311
Huttunen, J. K., Länsimies, E., Voutilainen, E., Ehnholm, C., Hietanen, E., Penttilä, I., Siitonen, O., & Rauramaa, R. (1979) · Circulation · doi:10.1161/01.cir.60.6.1220 · Cited by 300
Cholesterol and Coronary Heart Disease: A New Era
Grundy, S. M. (1986) · JAMA · doi:10.1001/jama.1986.03380200087027 · Cited by 287
High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
(1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90899-3 · Cited by 275
Gordon, T., Moore, F. E., Shurtleff, D., & Dawber, T. R. (1959) · Journal of Chronic Diseases · doi:10.1016/0021-9681(59)90002-5 · Cited by 177
Goldbourt, U., Holtzman, E., & Neufeld, H. N. (1985) · BMJ · doi:10.1136/bmj.290.6477.1239 · Cited by 169
ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATH
Keys, A. B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90280-9 · Cited by 111
Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions
Gutai, J. P., LaPorte, R. E., Kuller, L. H., Dai, W. S., Falvo-Gerard, L., & Caggiula, A. W. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90356-8 · Cited by 106
Factors associated with lipoprotein cholesterol levels. The Framingham study.
Wilson, P. W. F., Garrison, R. J., Abbott, R. D., & Castelli, W. P. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.3.273 · Cited by 98
Self-citationRelation of Body Fat Distribution to Metabolic Complications of Obesity
Kissebah, A. H., VYDELINFUM, N., MURRAY, R., EVANS, D. J., Hartz, A. J., Kalkhoff, R. K., & ADAMS, P. W. (1983) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198301000-00015 · Cited by 89
CHANGES IN PLASMA LIPIDS AND LIPOPROTEINS AFTER A MODIFIED FAT DIET
Ernst, N. D., Bowen, P. E., Fisher, M. R., Schaefer, E. J., & Levy, R. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90003-3 · Cited by 74
HDL Serum Cholesterol and 24–Year Mortality of Men in Finland
Keys, A. B., KARVONEN, M. J., Punsar, S., Menotti, A., Fidanza, F., & Farchi, G. (1984) · International Journal of Epidemiology · doi:10.1093/ije/13.4.428 · Cited by 74
The structure, function and metabolism of high-density lipoproteins: A status report.
Levy, R. I., & Bm, R. (1980) · PubMed · Cited by 32
Cited by
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Dietary influences on serum lipids and lipoproteins.
Grundy, S., & Denke, M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42625-2 · Cited by 1,038
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
Mensink, R. P., & Katan, M. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210705 · Cited by 542
Metadata
- Authors
- Abbott, R. D., Wilson, P. W., Kannel, W. B., & Castelli, W. P.
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-05
- Volume
- 8
- Issue
- 3
- Pages
- 207-211
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2075401586
- Cited by
- 436
- References
- 17
- FWCI
- 24.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.